Abstract
Thalidomide was used in the late 1950s and early 1960s as a sedative for morning sickness in pregnant women. It resulted in thousands of babies being born with various congenital anomalies, such as phocomelia. Subsequently, the drug was banned for this indication. Most of the survivors have become thalidomide adults and now they are in their fifties. We report the first case of a robot-assisted radical prostatectomy in a 54-year-old male with prostate cancer and phocomelia as a result of thalidomide embryopathy. He presented with a PSA of 3.3 and was diagnosed with Gleason 3 + 4 prostate cancer. An extra peritoneal approach was chosen due to his body habitus and to avoid extreme Trendelenburg tilt. Side docking with the da Vinci robot was employed and the prostatectomy was carried out in the standard extra peritoneal fashion. At 6 months’ follow-up his PSA is unrecordable and he is voiding well with minimal urinary incontinence, requiring 1 pad/day. We aim to outline our approach and highlight the technical modifications in this rare physically disabling condition.
References
Lenz W (1985) Thalidomide embryopathy in Germany, 1959–1961. Prog Clin Biol Res 163C:77–83
Lenz W (1962) Thalidomide and congenital abnormalities. Lancet 1:271–272
Newman CGH (1986) The thalidomide syndrome: risk of exposure and spectrum of malformations. Clin Perinatol 13(3):555–573
Källén B, Rahmani TM, Winberg J (1984) Infants with congenital limb reduction registered in the Swedish Register of Congenital Malformations. Teratology. 29(1):73–85
Millen JW (1962) Thalidomide and limb deformities. Lancet 2(7256):599–600
Strömland K, Miller MT (1993) Thalidomide embryopathy: revisited 27 years later. Acta Ophthalmol (Copenh) 71(2):238–245
Miller MT, Ventura L, Strömland K (2009) Thalidomide and misoprostol: ophthalmologic manifestations and associations both expected and unexpected. Birth Defects Res A Clin Mol Teratol 85(8):667–676
Ruffing L (1980) The spine in the thalidomide-embryopathy. Fortschr Med 98(11):405–409
Smithells RW, Newman CG (1992) Recognition of thalidomide defects. J Med Genet 29(10):716
Newman CG (1985) Teratogen update: clinical aspects of thalidomide embryopathy—a continuing preoccupation. Teratology. 32(1):133–144
Henkel L, Willert HG (1969) Dysmelia. Bone Joint J 51(3):399–414
Speirs AL (1962) Thalidomide and congenital abnormalities. Lancet 279(7224):303–305
Uffort EE, Jensen JC (2011) Side docking the robot for robotic laparoscopic radical prostatectomy. JSLS 15:200–202
Ploussard G, Xylinas E, Salomon L et al (2010) Robot-assisted extraperitoneal laparoscopic radical prostatectomy: experience in a high-volume laparoscopy reference centre. BJU Int 105:1155–1160
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest to declare.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study. "Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal".
Rights and permissions
About this article
Cite this article
Kusuma, V.R.M., Ashton, A., Moschanos, D. et al. Robotic assisted radical prostatectomy for localised prostate cancer in thalidomide generation. J Robotic Surg 12, 373–376 (2018). https://doi.org/10.1007/s11701-017-0739-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11701-017-0739-4